ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
위궤양 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 5.2%로 55억 5,000만 달러로 성장할 것입니다. 예측 기간의 성장은 진단 기술 향상, 건강에 해로운 식습관 개선, 양성자 펌프 억제제(PPI)를 포함한 치료 옵션의 발전, 질병 부담 증가에 기여하는 고령화, 신흥 시장에서의 의료 인프라 확대 등에 기인하는 것으로 보입니다. 예측 기간 동안 주요 동향으로는 유효성을 높이기 위한 병용요법으로의 전환, 최소침습적 치료에 대한 선호도 증가, 질병 관리에 디지털 헬스 솔루션의 통합, 일반의약품(OTC) 궤양 치료제 수요 증가, 궤양 치료에 대한 맞춤형 의료 접근법 확대 등이 있습니다.
향후 5년간 5.2%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가들 간의 관세의 영향에 기인합니다. 관세 인상은 인도와 캐나다에서 수입되는 양성자 펌프 억제제(PPI)와 헬리코박터 파일로리균 검사 키트의 가격을 상승시켜 궤양 치료 기간을 악화시키고 소화기내과 약품 비용을 증가시켜 미국 환자들에게 부담을 줄 가능성이 높습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
노인 인구의 증가는 향후 몇 년 동안 위궤양 시장의 성장을 견인할 것으로 예상됩니다. 노년 인구는 일반적으로 65세 이상의 개인을 의미하며, 노화에 따른 특유의 건강 문제에 직면해 있습니다. 이러한 증가의 주요 원인은 세계 여러 지역의 출산율 감소와 더불어 평균 수명 연장으로 이어진 의료기술의 발전에 기인합니다. 위궤양은 합병증 위험을 높이는 비스테로이드성 항염증제의 잦은 사용과 점막 보호 기능 저하로 인해 노인에게 많이 발생합니다. 예를 들어, 2024년 1월 미국 비영리단체인 인구문제연구소(PRB)는 65세 이상 미국인 인구가 2022년 5,800만 명에서 2050년 8,200만 명으로 47% 증가할 것으로 예상했습니다. 또한, 이 연령대가 전체 인구에서 차지하는 비중은 17%에서 23%까지 상승할 것으로 예측되어 미국의 고령화 추세가 두드러지게 나타나고 있습니다. 이러한 예측은 다양한 분야에서 노인의 건강관리 수요에 대응해야 할 필요성이 증가하고 있음을 강조합니다. 이처럼 노인 인구의 증가가 위궤양 시장의 성장을 견인하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 위궤양 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 위궤양 시장 : 성장률 분석
세계의 위궤양 시장 실적 : 규모와 성장, 2019-2024
세계의 위궤양 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 위궤양 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 위궤양 시장 : 약물 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
양성자 펌프 억제제(PPI)
H2 길항제
제산제
항생제
세포 보호제
기타 약물 클래스
세계의 위궤양 시장 진단별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
변검사
내시경 검사
영상 검사
컴퓨터 단층촬영(CT) 스캔
X선
혈액 검사
기타 진단
세계의 위궤양 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
비경구
기타 투여 경로
세계의 위궤양 시장 : 유통 채널별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원 약국
소매 약국
온라인 약국
기타 유통 채널
세계의 위궤양 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원
전문 클리닉
홈케어
기타 최종사용자
세계의 위궤양 시장 : 하위 세분화 양성자 펌프 억제제(PPI), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
오메프라졸
란소프라졸
판토프라졸
에소메프라졸
라베프라졸
세계의 위궤양 시장 : 하위 세분화 H2 길항제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
라니티딘
파모티딘
시메티딘
니자티딘
세계의 위궤양 시장 : 하위 세분화 제산제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
탄산칼슘
수산화마그네슘
수산화알루미늄
중탄산나트륨
세계의 위궤양 시장 : 하위 세분화 항생제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
아목시실린
클라리트로마이신
메트로니다졸
테트라사이클린
세계의 위궤양 시장 : 하위 세분화 세포 보호제(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
수크랄페이트
미소프로스톨
차살리실산 비스무트
세계의 위궤양 시장 : 하위 세분화 기타 약물 클래스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
프로스타글란딘 유사체
소화관 운동 촉진제
허브 요법과 대체요법
병용요법
제7장 지역별·국가별 분석
세계의 위궤양 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 위궤양 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
위궤양 시장 : 경쟁 구도
위궤양 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Abbott Laboratories
Novartis AG
GlaxoSmithKline plc
Takeda Pharmaceutical Co. Ltd
Amgen Inc.
Boehringer Ingelheim
Viatris Inc.
Daiichi Sankyo Company Limited
Eisai Co. Ltd
Cadila Pharmaceuticals
Dr. Reddy's Laboratories Ltd.
Hikma Pharmaceuticals PLC
Lupin Limited
Yuhan Corporation
Daewoong Pharmaceutical Co. Ltd
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
위궤양 시장 2029 : 새로운 기회를 제공하는 국가
위궤양 시장 2029 : 새로운 기회를 제공하는 부문
위궤양 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Gastric ulcers, also known as peptic ulcers, are open sores on the stomach's inner lining caused by the corrosive action of stomach acid. They often result in burning stomach pain, indigestion, and discomfort. These ulcers typically arise from an imbalance between stomach acid, the enzyme pepsin, and the protective mucosal barrier lining the stomach and duodenum.
The primary drug classes used to treat gastric ulcers include proton pump inhibitors (PPIs), H2 antagonists, antacids, antibiotics, cytoprotective agents, and others. Proton pump inhibitors are medications that reduce stomach acid production by inhibiting the proton pump enzyme in gastric cells. Gastric ulcers can be diagnosed through stool tests, endoscopies, imaging tests, computed tomography (CT) scans, X-rays, blood tests, and other methods. Treatment routes include oral and parenteral administration, among others. Distribution channels primarily consist of hospital pharmacies, retail pharmacies, and online pharmacies, and the treatments are utilized by various end-users such as hospitals, specialty clinics, and homecare settings.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The gastric ulcers market research report is one of a series of new reports from The Business Research Company that provides gastric ulcers market statistics, including gastric ulcers industry global market size, regional shares, competitors with a gastric ulcers market share, detailed gastric ulcers market segments, market trends and opportunities, and any further data you may need to thrive in the gastric ulcers industry. This gastric ulcers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The gastric ulcers market size has grown strongly in recent years. It will grow from $4.29 billion in 2024 to $4.53 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to the rising prevalence of helicobacter pylori infections, increasing use of nonsteroidal anti-inflammatory drugs (NSAIDs), growing geriatric population globally, rising awareness campaigns for gastric ulcer prevention and increasing incidence of stress-related disorders.
The gastric ulcers market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to improvements in diagnostic techniques, adoption of unhealthy dietary habits, advancements in treatment options, including proton pump inhibitors (PPIs), aging population contributing to higher disease burden and expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include shift towards combination therapies for enhanced efficacy, growing preference for minimally invasive treatment procedures, integration of digital health solutions in disease management, rising demand for over-the-counter (OTC) ulcer medications and expansion of personalized medicine approaches in ulcer treatment.
The forecast of 5.2% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of proton pump inhibitors (PPIs) and H. pylori test kits imported from India and Canada, worsening ulcer healing times and increasing gastroenterology medication costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growing geriatric population is expected to drive the growth of the gastric ulcers market in the coming years. The geriatric population refers to individuals typically aged 65 and older, who face unique health challenges associated with aging. This increase is primarily due to advancements in healthcare, which have led to longer life expectancies, alongside declining birth rates in many regions worldwide. Gastric ulcers are more common among the elderly due to the frequent use of NSAIDs and reduced mucosal protection, both of which heighten the risk of complications. For example, in January 2024, the Population Reference Bureau (PRB), a US-based non-profit organization, reported that the population of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, a 47% increase. Moreover, this age group's share of the total population is projected to rise from 17% to 23%, highlighting a significant aging trend in the U.S. population. These projections emphasize the growing need to address the healthcare needs of older adults across various sectors. As such, the increasing geriatric population is driving the growth of the gastric ulcers market.
Key companies in the gastric ulcer market are focusing on developing innovative products, such as new drug formulations, to improve treatment effectiveness and minimize side effects. New formulation drugs involve the creation of medications with novel combinations of active ingredients, delivery methods, or dosage forms aimed at enhancing their efficacy, safety, and patient adherence. For example, in June 2024, Akums Drugs and Pharmaceuticals Ltd., an India-based pharmaceutical manufacturer, introduced Rabeprazole + Levosulpiride SR Capsules. These capsules are designed to provide better relief for conditions like gastro-oesophageal reflux disease (GERD) and other gastrointestinal tract (GIT) disorders. The combination of a proton pump inhibitor and a prokinetic agent effectively treats gastrointestinal issues, including GERD and gastric ulcers. This formulation not only decreases gastric acid secretion but also improves gastric motility, offering comprehensive relief from symptoms such as heartburn and indigestion.
In May 2022, Dr. Reddy's Laboratories partnered with HK Inno.N. Corporation to supply and commercialize Tegoprazan, a novel molecule for gastrointestinal diseases, in India and six key emerging markets. Under this partnership, HK Inno.N. will manufacture and supply Tegoprazan, while Dr. Reddy's will oversee local clinical development, registration, marketing, and sales in the licensed territories. HK Inno.N. Corporation is a South Korea-based pharmaceutical company specializing in drugs for gastric ulcers.
Major companies operating in the gastric ulcers market are Pfizer Inc., Merck & Co Inc., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd, Amgen Inc., Boehringer Ingelheim, Viatris Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd, Cadila Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Yuhan Corporation, Daewoong Pharmaceutical Co. Ltd, Cadila Healthcare Ltd, Novitium Pharma LLC
North America was the largest region in the gastric ulcers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric ulcers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the gastric ulcers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The gastric ulcers market consists of revenues earned by entities through barium swallow, H. pylori testing, and biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastric ulcers market also includes sales of amoxicillin, clarithromycin, metronidazole, omeprazole, and lansoprazole. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Gastric Ulcers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on gastric ulcers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for gastric ulcers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gastric ulcers market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Proton Pump Inhibitors (PPI); H2 Antagonists; Antacids; Antibiotics; Cytoprotective Agents; Other Drug Classes
2) By Diagnosis: Stool Test; Endoscopy; Imaging Tests; Computed Tomography (CT) Scan; X-ray; Blood Tests; Other Diagnosis
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy; Other Distribution Channels
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End Users
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Gastric Ulcers Market Characteristics
3. Gastric Ulcers Market Trends And Strategies
4. Gastric Ulcers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Gastric Ulcers Growth Analysis And Strategic Analysis Framework
5.1. Global Gastric Ulcers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gastric Ulcers Market Growth Rate Analysis
5.4. Global Gastric Ulcers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gastric Ulcers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gastric Ulcers Total Addressable Market (TAM)
6. Gastric Ulcers Market Segmentation
6.1. Global Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors (PPI)
H2 Antagonists
Antacids
Antibiotics
Cytoprotective Agents
Other Drug Classes
6.2. Global Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Stool Test
Endoscopy
Imaging Tests
Computed Tomography (CT) Scan
X-ray
Blood Tests
Other Diagnosis
6.3. Global Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Route Of Administrations
6.4. Global Gastric Ulcers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Other Distribution Channels
6.5. Global Gastric Ulcers Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End Users
6.6. Global Gastric Ulcers Market, Sub-Segmentation Of Proton Pump Inhibitors (PPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Omeprazole
Lansoprazole
Pantoprazole
Esomeprazole
Rabeprazole
6.7. Global Gastric Ulcers Market, Sub-Segmentation Of H2 Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ranitidine
Famotidine
Cimetidine
Nizatidine
6.8. Global Gastric Ulcers Market, Sub-Segmentation Of Antacids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcium Carbonate
Magnesium Hydroxide
Aluminum Hydroxide
Sodium Bicarbonate
6.9. Global Gastric Ulcers Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amoxicillin
Clarithromycin
Metronidazole
Tetracycline
6.10. Global Gastric Ulcers Market, Sub-Segmentation Of Cytoprotective Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sucralfate
Misoprostol
Bismuth Subsalicylate
6.11. Global Gastric Ulcers Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prostaglandin Analogues
Prokinetic Agents
Herbal And Alternative Medications
Combination Therapies
7. Gastric Ulcers Market Regional And Country Analysis
7.1. Global Gastric Ulcers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gastric Ulcers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Gastric Ulcers Market
8.1. Asia-Pacific Gastric Ulcers Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Gastric Ulcers Market
9.1. China Gastric Ulcers Market Overview
9.2. China Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Gastric Ulcers Market
10.1. India Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Gastric Ulcers Market
11.1. Japan Gastric Ulcers Market Overview
11.2. Japan Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Gastric Ulcers Market
12.1. Australia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Gastric Ulcers Market
13.1. Indonesia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Gastric Ulcers Market
14.1. South Korea Gastric Ulcers Market Overview
14.2. South Korea Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Gastric Ulcers Market
15.1. Western Europe Gastric Ulcers Market Overview
15.2. Western Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Gastric Ulcers Market
16.1. UK Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Gastric Ulcers Market
17.1. Germany Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Gastric Ulcers Market
18.1. France Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Gastric Ulcers Market
19.1. Italy Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Gastric Ulcers Market
20.1. Spain Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Gastric Ulcers Market
21.1. Eastern Europe Gastric Ulcers Market Overview
21.2. Eastern Europe Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Gastric Ulcers Market
22.1. Russia Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Gastric Ulcers Market
23.1. North America Gastric Ulcers Market Overview
23.2. North America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Gastric Ulcers Market
24.1. USA Gastric Ulcers Market Overview
24.2. USA Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Gastric Ulcers Market
25.1. Canada Gastric Ulcers Market Overview
25.2. Canada Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Gastric Ulcers Market
26.1. South America Gastric Ulcers Market Overview
26.2. South America Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Gastric Ulcers Market
27.1. Brazil Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Gastric Ulcers Market
28.1. Middle East Gastric Ulcers Market Overview
28.2. Middle East Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Gastric Ulcers Market
29.1. Africa Gastric Ulcers Market Overview
29.2. Africa Gastric Ulcers Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gastric Ulcers Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gastric Ulcers Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Gastric Ulcers Market Competitive Landscape And Company Profiles
30.1. Gastric Ulcers Market Competitive Landscape
30.2. Gastric Ulcers Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Gastric Ulcers Market Other Major And Innovative Companies
31.1. Abbott Laboratories
31.2. Novartis AG
31.3. GlaxoSmithKline plc
31.4. Takeda Pharmaceutical Co. Ltd
31.5. Amgen Inc.
31.6. Boehringer Ingelheim
31.7. Viatris Inc.
31.8. Daiichi Sankyo Company Limited
31.9. Eisai Co. Ltd
31.10. Cadila Pharmaceuticals
31.11. Dr. Reddy's Laboratories Ltd.
31.12. Hikma Pharmaceuticals PLC
31.13. Lupin Limited
31.14. Yuhan Corporation
31.15. Daewoong Pharmaceutical Co. Ltd
32. Global Gastric Ulcers Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Gastric Ulcers Market
34. Recent Developments In The Gastric Ulcers Market
35. Gastric Ulcers Market High Potential Countries, Segments and Strategies
35.1 Gastric Ulcers Market In 2029 - Countries Offering Most New Opportunities
35.2 Gastric Ulcers Market In 2029 - Segments Offering Most New Opportunities
35.3 Gastric Ulcers Market In 2029 - Growth Strategies
